A Model of Dendritic Cell Therapy for Melanoma

Department of Mathematics, Harvey Mudd College Claremont, CA, USA.
Frontiers in Oncology 03/2013; 3:56. DOI: 10.3389/fonc.2013.00056
Source: PubMed


Dendritic cells are a promising immunotherapy tool for boosting an individual's antigen-specific immune response to cancer. We develop a mathematical model using differential and delay-differential equations to describe the interactions between dendritic cells, effector-immune cells, and tumor cells. We account for the trafficking of immune cells between lymph, blood, and tumor compartments. Our model reflects experimental results both for dendritic cell trafficking and for immune suppression of tumor growth in mice. In addition, in silico experiments suggest more effective immunotherapy treatment protocols can be achieved by modifying dose location and schedule. A sensitivity analysis of the model reveals which patient-specific parameters have the greatest impact on treatment efficacy.

Download full-text


Available from: Lisette Depillis
  • Source

    Full-text · Article · Sep 2013 · Frontiers in Oncology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mathematical models of tumor–immune interactions provide an analytical framework in which to address specific questions regarding tumor–immune dynamics and tumor treatment options. We present a mathematical model, in the form of a system of ordinary differential equations (ODEs), that governs cancer growth on a cell population level. In addition to a cancer cell population, the model includes a population of Natural Killer (NK) and CD8+ T immune cells. Our goal is to understand the dynamics of immune-mediated tumor rejection, in addition to exploring results of applying combination immune, vaccine and chemotherapy treatments. We characterize the ODE system dynamics by locating equilibrium points, determining stability properties, performing a bifurcation analysis, and identifying basins of attraction. These system characteristics are useful, not only for gaining a broad understanding of the specific system dynamics, but also for helping to guide the development of combination therapies. Additionally, a parameter sensitivity analysis suggests that the model can predict which patients may respond positively to treatment. Numerical simulations of mixed chemo-immuno and vaccine therapy using both mouse and human parameters are presented. Simulations of tumor growth using different levels of immune stimulating ligands, effector cells, and tumor challenge, are able to reproduce data from published studies. We illustrate situations for which neither chemotherapy nor immunotherapy alone are sufficient to control tumor growth, but in combination the therapies are able to eliminate the entire tumor.
    No preview · Chapter · Jan 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pancreatic cancer is one of the most deadly types of cancer and has extremely poor prognosis. This malignancy typically induces only limited cellular immune responses, the magnitude of which can increase with the number of encountered cancer cells. On the other hand, pancreatic cancer is highly effective at evading immune responses by inducing polarization of pro-inflammatory M1 macrophages into anti-inflammatory M2 macrophages, and promoting expansion of myeloid derived suppressor cells, which block the killing of cancer cells by cytotoxic T cells. These factors allow immune evasion to predominate, promoting metastasis and poor responsiveness to chemotherapies and immunotherapies. In this paper we develop a mathematical model of pancreatic cancer, and use it to qualitatively explain a variety of biomedical and clinical data. The model shows that drugs aimed at suppressing cancer growth are effective only if the immune induced cancer cell death lies within a specific range, that is, the immune system has a specific window of opportunity to effectively suppress cancer under treatment. The model results suggest that tumor growth rate is affected by complex feedback loops between the tumor cells, endothelial cells and the immune response. The relative strength of the different loops determines the cancer growth rate and its response to immunotherapy. The model could serve as a starting point to identify optimal nodes for intervention against pancreatic cancer.
    Full-text · Article · Mar 2014 · Journal of Theoretical Biology
Show more